Tirzepatide Dosage Guide
Complete guide to Tirzepatide dosing protocols, administration methods, and safety considerations for research purposes.
NOT Medical Advice
The dosage and calculator information provided is for educational and research purposes only. Peptides are not approved by the FDA for human use. Individual responses vary significantly. Always consult with a qualified healthcare professional before making any decisions related to peptide research or use.
Dosage Overview
Dose Range
2.5 mg - 15 mg
Route
subcutaneous
Frequency
Weekly
Cycle Length
12-52 weeks
Reconstitution
Vial Size
5 mg
BAC Water
2.0 ml
Concentration
2,500 mcg/ml
Detailed Dosage Information
Start at 2.5mg weekly, titrate every 4 weeks through 5mg, 7.5mg, 10mg, 12.5mg, to maximum 15mg weekly. Full titration takes approximately 20 weeks.
Administration Method
Subcutaneous injection once weekly. Rotate injection sites. Slower titration may help reduce GI side effects.
Research Use Only: All dosage ranges and calculations are derived from published research literature and are provided for educational purposes. These are not prescriptions or medical recommendations. Consult a healthcare professional before any use.
Quick Calculator
Concentration: 2,500 mcg/ml
Volume to inject: 1.00 ml
Syringe units (U-100): 100.0 units
Pre-filled with Tirzepatide defaults. Adjust values as needed.
Side Effects to Monitor
Similar to semaglutide: nausea, diarrhea, vomiting, constipation, abdominal pain, decreased appetite. Generally improve with continued use.
Safety Considerations & Risks
Same thyroid cancer warnings as GLP-1 agonists. Risk of pancreatitis, gallbladder disease, hypoglycemia when combined with insulin or sulfonylureas.